頚椎症治療の世界市場レポート 2024

頚椎症治療の市場規模は、今後数年間で大幅な成長が見込まれています。2028年には6.2%の年間複合成長率（CAGR）で75億1,000万米ドルに成長すると予想されます。予測期間で予想される成長は、ヘルスケア投資の増加、低侵襲処置の採用、患者の意識と教育の向上、予防策への注目の高まり、治療アプローチへの遠隔医療の統合に起因すると考えられます。予測期間に予想される主な動向には、個別化された治療計画の開発、非外科的介入の台頭、在宅治療ソリューションの作成、デジタルヘルスプラットフォームの統合、総合的かつ学際的なアプローチの重視などが含まれます。

頚椎症治療市場の成長は、この症状の蔓延の増加によって促進されると予想されます。頸椎症は首の頸椎の関節や椎間板に影響を与える変性疾患であり、痛みの軽減、活動レベルの維持、脊髄や神経への不可逆的な損傷の防止を目的とした治療が必要です。これらの治療法は、頸椎症に罹患している人の全体的な健康状態を向上させることを目的としています。たとえば、2021年4月の米国整形外科医学会のデータによると、60歳以上の個人の85%以上が頚椎症に罹患していると報告されています。したがって、この症状の蔓延の拡大は、頚椎症治療市場の成長の背後にある重要な促進力となっています。

ヘルスケア支出の増加により、頚椎症治療市場の拡大が促進される見込みです。ヘルスケア支出には、主に健康増進に焦点を当てた、家族計画、栄養、緊急医療支援などの医療サービスの提供に関連するコストが含まれます。ヘルスケア費の増加は、患者の意識を高め、早期診断を促進し、頸椎症の包括的な管理を可能にするのに役立ちます。たとえば、2022年3月にメディケア・メディケイドサービスセンターが発行した2021年から2030年の国民医療支出（NHE）報告書に概要が示されているように、国民医療支出は2021年から2030年の間に平均年間成長率5.1%の伸びを示し、2030年には約6兆8,000億米ドルに達する可能性があると予測されています。その結果、増大するヘルスケア費は頚椎症治療市場を推進する重要な促進力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の頚椎症治療市場の促進要因と抑制要因
  • 市場の促進要因
  • 市場の抑制要因
• 世界の頚椎症治療の市場規模実績と成長、2018年～2023年
• 世界の頚椎症治療の市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の頚椎症治療市場、治療の種類別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
• 投薬
• 理学療法
• 手術
• 世界の頚椎症治療市場、用途別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
• 若者
• 高齢者
• 世界の頚椎症治療市場、エンドユーザー別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
• 病院
• 外来手術センター
• ホームケア設定

第7章 地域と国の分析

• 世界の頚椎症治療市場、地域別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 世界の頚椎症治療市場、国別、実績と予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 頚椎症治療市場の競合情勢
• 頚椎症治療市場の企業プロファイル
  • Johnson &Johnson
  • Merck &Co Inc.
  • AbbVie Inc.
  • GlaxoSmithKline Plc
  • Medtronic PLC

第31章 その他の大手と革新的な企業

• CH Boehringer Sohn AG &Co. KG
• Amgen Inc.
• Stryker Corporation
• B. Braun SE
• Zimmer Biomet Holdings Inc.
• UCB Pharma SA
• Integra LifeSciences Holdings Corp（Integra）
• Integra LifeSciences
• NuVasive Inc.
• Globus Medical Inc.
• Orthofix Medical Inc.
• Aesculap Implant Systems LLC
• Titan Spine Inc.
• Exactech Inc.
• SeaSpine Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Cervical spondylosis treatment involves therapeutic interventions for a degenerative condition affecting the cervical spine (neck region) caused by wear and tear of spinal discs, joints, and bones. These treatments aim to alleviate pain, maintain individuals' activity levels, and prevent irreversible damage to the spinal cord and nerves.

The primary types of cervical spondylosis treatment include medications, physical therapy, and surgery. Medications are substances used for diagnosing, preventing, treating, or managing various medical conditions and diseases. In the context of cervical spondylosis treatment, medications are employed to reduce inflammation and alleviate symptoms associated with the condition. These treatments cater to both youth and the elderly and are administered in different settings, such as hospitals, ambulatory surgical centers, and homecare.

The cervical spondylosis treatment market research report is one of a series of new reports from The Business Research Company that provides cervical spondylosis treatment market statistics, including cervical spondylosis treatment industry global market size, regional shares, competitors with a cervical spondylosis treatment market share, detailed cervical spondylosis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the cervical spondylosis treatment industry. This cervical spondylosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cervical spondylosis treatment market size has grown strongly in recent years. It will grow from $5.51 billion in 2023 to $5.9 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The growth observed in the historic period can be attributed to factors such as an aging population, the increased prevalence of sedentary lifestyles, growing awareness of cervical spondylosis, expansion of healthcare infrastructure, and a rise in musculoskeletal disorders.

The cervical spondylosis treatment market size is expected to see strong growth in the next few years. It will grow to $7.51 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The anticipated growth in the forecast period can be attributed to increasing healthcare investments, the adoption of minimally invasive procedures, a rise in patient awareness and education, a growing focus on preventive measures, and the integration of telemedicine in treatment approaches. Major trends expected in the forecast period include the development of personalized treatment plans, the rise of non-surgical interventions, the creation of home-based therapeutic solutions, the integration of digital health platforms, and an emphasis on holistic and multidisciplinary approaches.

The growth of the cervical spondylosis treatment market is anticipated to be propelled by the increasing prevalence of this condition. Cervical spondylosis, a degenerative condition impacting the joints and discs in the neck's cervical spine, necessitates treatments aimed at alleviating pain, preserving activity levels, and preventing irreversible damage to the spinal cord and nerves. These treatments aim to enhance the overall well-being of individuals affected by cervical spondylosis. For instance, data from the American Academy of Orthopedic Surgeons in April 2021 revealed that over 85% of individuals aged 60 and above were reported to be affected by cervical spondylosis. Consequently, the escalating prevalence of this condition is a key driving force behind the growth of the cervical spondylosis treatment market.

The rise in healthcare expenditure is poised to fuel the expansion of the cervical spondylosis treatment market. Healthcare expenditure encompasses costs associated with providing health services, including aspects such as family planning, nutrition, and emergency medical assistance, with a primary focus on promoting health. Increased healthcare spending is instrumental in elevating patient awareness, facilitating early diagnosis, and enabling comprehensive management of cervical spondylosis. For instance, as outlined in the 2021-2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services in March 2022, national health spending was projected to experience an average annual growth rate of 5.1% between 2021 and 2030, potentially reaching approximately $6.8 trillion by 2030. Consequently, the escalating healthcare expenditure serves as a significant driver propelling the cervical spondylosis treatment market.

Product innovation is emerging as a prominent trend within the cervical spondylosis treatment market, with major companies actively introducing innovative solutions to maintain their market positions. An illustration of this trend unfolded in March 2021 when Sleepsia, a US-based manufacturer renowned for innovative pillows, unveiled a novel cervical pillow tailored specifically to alleviate symptoms associated with cervical spondylosis, particularly neck pain. This new pillow is meticulously designed to strike a balance between firmness and softness, providing optimal support. Its ergonomic design facilitates a natural curvature for the neck, aiding in mitigating spinal issues that can arise from incorrect mattress or pillow usage. Furthermore, the pillow features hypoallergenic fabric that resists dust mites, addressing additional concerns related to allergies.

Prominent players in the market are strategically prioritizing the development of cutting-edge products, such as spinal support systems, to address the changing demands of patients and advancements in technology. Specifically, Aspen Medical Products, a US-based provider of solutions for pain and mobility management, unveiled the VRTX System in October 2023. This groundbreaking spine support system is meticulously crafted to offer comprehensive coverage from the cervical to sacrum regions. The VRTX System aims to revolutionize acute spinal care through its user-friendly prefabricated design and easily adjustable sizing, enabling healthcare professionals to promptly fit patients and stabilize their spines. This off-the-shelf solution is expected to reduce hospital stays, minimize complications, and enhance operational efficiency by optimizing time and inventory management. Featuring prefabricated components like CTO, TLSO, LSO, and CTLSO, each element within the VRTX System ensures optimal motion restriction and can be tailored to meet the specific needs of individual patients. This modular approach supports standardization of products and services within hospitals, promoting staff efficiency and elevating overall patient care.

In August 2023, ZimVie Inc., a US-based life sciences company operating in the dental and spine markets, announced an expansion of its collaboration agreement with Brainlab, a Germany-based leader in spine imaging, planning, and navigation solutions, incorporating robotic imaging, surgical assistance, and mixed reality technologies. This collaboration aims to merge ZimVie's Vital and Virage fixation systems with Brainlab's spine and trauma navigation technologies. By leveraging Brainlab's expertise, surgeons can effectively plan and execute spinal procedures, accurately position pedicle screws, and minimize radiation exposure, thereby enhancing the precision and safety of spinal surgeries.

Major companies operating in the cervical spondylosis treatment market report are Johnson & Johnson, Merck & Co Inc., AbbVie Inc., GlaxoSmithKline PLC, Medtronic PLC, C.H. Boehringer Sohn AG & Co. KG, Amgen Inc., Stryker Corporation, B. Braun SE, Zimmer Biomet Holdings Inc., UCB Pharma S.A., Integra LifeSciences Holdings Corp (Integra), Integra LifeSciences, NuVasive Inc., Globus Medical Inc., Orthofix Medical Inc., Aesculap Implant Systems LLC, Titan Spine Inc., Exactech Inc., SeaSpine Inc., RTI Surgical, Xtant Medical Holdings Inc., Zavation Medical Products LLC, Wenzel Spine Inc., Life Spine Inc., Spineology Inc., VGI Medical LLC, Dynamic Spine Inc., Synthes Holding AG, ZygoFix Ltd.

North America was the dominant region in the cervical spondylosis treatment market in 2023. The regions covered in the cervical spondylosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cervical spondylosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cervical spondylosis treatment market consists of revenues earned by entities by providing physical therapy services, neck traction services, diagnosis, consultation, and surgical services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cervical spondylosis treatment market also includes the sales of nonsteroidal anti-inflammatory drugs, corticosteroids, and anti-seizure medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cervical Spondylosis Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cervical spondylosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cervical spondylosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cervical spondylosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type of Treatment: Medications; Physical Therapy; Surgery
• 2) By Application: Youth; Elderly
• 3) By End User: Hospitals; Ambulatory Surgical Centers; Homecare Settings
• Companies Mentioned: Johnson & Johnson; Merck & Co Inc.; AbbVie Inc.; GlaxoSmithKline Plc; Medtronic PLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cervical Spondylosis Treatment Market Characteristics

3. Cervical Spondylosis Treatment Market Trends And Strategies

4. Cervical Spondylosis Treatment Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Cervical Spondylosis Treatment Market Size and Growth

• 5.1. Global Cervical Spondylosis Treatment Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Cervical Spondylosis Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Cervical Spondylosis Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cervical Spondylosis Treatment Market Segmentation

• 6.1. Global Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Medications
• Physical Therapy
• Surgery
• 6.2. Global Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Youth
• Elderly
• 6.3. Global Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Homecare Settings

7. Cervical Spondylosis Treatment Market Regional And Country Analysis

• 7.1. Global Cervical Spondylosis Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Cervical Spondylosis Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cervical Spondylosis Treatment Market

• 8.1. Asia-Pacific Cervical Spondylosis Treatment Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cervical Spondylosis Treatment Market

• 9.1. China Cervical Spondylosis Treatment Market Overview
• 9.2. China Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cervical Spondylosis Treatment Market

• 10.1. India Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cervical Spondylosis Treatment Market

• 11.1. Japan Cervical Spondylosis Treatment Market Overview
• 11.2. Japan Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cervical Spondylosis Treatment Market

• 12.1. Australia Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cervical Spondylosis Treatment Market

• 13.1. Indonesia Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cervical Spondylosis Treatment Market

• 14.1. South Korea Cervical Spondylosis Treatment Market Overview
• 14.2. South Korea Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cervical Spondylosis Treatment Market

• 15.1. Western Europe Cervical Spondylosis Treatment Market Overview
• 15.2. Western Europe Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cervical Spondylosis Treatment Market

• 16.1. UK Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cervical Spondylosis Treatment Market

• 17.1. Germany Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cervical Spondylosis Treatment Market

• 18.1. France Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cervical Spondylosis Treatment Market

• 19.1. Italy Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cervical Spondylosis Treatment Market

• 20.1. Spain Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cervical Spondylosis Treatment Market

• 21.1. Eastern Europe Cervical Spondylosis Treatment Market Overview
• 21.2. Eastern Europe Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cervical Spondylosis Treatment Market

• 22.1. Russia Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cervical Spondylosis Treatment Market

• 23.1. North America Cervical Spondylosis Treatment Market Overview
• 23.2. North America Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cervical Spondylosis Treatment Market

• 24.1. USA Cervical Spondylosis Treatment Market Overview
• 24.2. USA Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cervical Spondylosis Treatment Market

• 25.1. Canada Cervical Spondylosis Treatment Market Overview
• 25.2. Canada Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cervical Spondylosis Treatment Market

• 26.1. South America Cervical Spondylosis Treatment Market Overview
• 26.2. South America Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cervical Spondylosis Treatment Market

• 27.1. Brazil Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cervical Spondylosis Treatment Market

• 28.1. Middle East Cervical Spondylosis Treatment Market Overview
• 28.2. Middle East Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cervical Spondylosis Treatment Market

• 29.1. Africa Cervical Spondylosis Treatment Market Overview
• 29.2. Africa Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cervical Spondylosis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Cervical Spondylosis Treatment Market Competitive Landscape
• 30.2. Cervical Spondylosis Treatment Market Company Profiles
  • 30.2.1. Johnson & Johnson
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Merck & Co Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. AbbVie Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. GlaxoSmithKline Plc
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Medtronic PLC
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Cervical Spondylosis Treatment Market Other Major And Innovative Companies

• 31.1. C.H. Boehringer Sohn AG & Co. KG
• 31.2. Amgen Inc.
• 31.3. Stryker Corporation
• 31.4. B. Braun SE
• 31.5. Zimmer Biomet Holdings Inc.
• 31.6. UCB Pharma S.A.
• 31.7. Integra LifeSciences Holdings Corp (Integra)
• 31.8. Integra LifeSciences
• 31.9. NuVasive Inc.
• 31.10. Globus Medical Inc.
• 31.11. Orthofix Medical Inc.
• 31.12. Aesculap Implant Systems LLC
• 31.13. Titan Spine Inc.
• 31.14. Exactech Inc.
• 31.15. SeaSpine Inc.

32. Global Cervical Spondylosis Treatment Market Competitive Benchmarking

33. Global Cervical Spondylosis Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cervical Spondylosis Treatment Market

35. Cervical Spondylosis Treatment Market Future Outlook and Potential Analysis

• 35.1 Cervical Spondylosis Treatment Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Cervical Spondylosis Treatment Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Cervical Spondylosis Treatment Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer